Biomarker shows potential to predict immunotherapy benefit for breast cancer patients

[News]

A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

More... (https://www.news-medical.net/news/20210727/Biomarker-shows-potential-to-predict-immunotherapy-benefit-for-breast-cancer-patients.aspx)